Betta Pharmaceuticals Co., Ltd.

SZSE:300558 Stok Raporu

Piyasa değeri: CN¥20.7b

Betta Pharmaceuticals Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Betta Pharmaceuticals şirketinin kazançları yıllık ortalama -3.4% oranında azalırken, Pharmaceuticals sektörünün kazançları yıllık 9.1% oranında artan oldu. Gelirler yıllık ortalama 10.8% oranında artan oldu. Betta Pharmaceuticals şirketinin öz sermaye getirisi 7.8% olup, net marjı 16.7% dir.

Anahtar bilgiler

-3.4%

Kazanç büyüme oranı

-4.4%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı10.8%
Özkaynak getirisi7.8%
Net Marj16.7%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Recent updates

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Sep 30
Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 07
Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

Jul 30
Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

Apr 23
Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Apr 16
What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Gelir ve Gider Dağılımı

Betta Pharmaceuticals nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:300558 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 242,7574601,270556
30 Jun 242,6434241,185562
31 Mar 242,6603951,201618
31 Dec 232,4563481,121640
30 Sep 232,7573471,318686
30 Jun 232,4371991,145717
31 Mar 232,3241131,181768
31 Dec 222,3771451,236700
30 Sep 222,1841391,198682
30 Jun 222,3442631,308640
31 Mar 222,2123191,156555
01 Jan 222,2463831,141566
30 Sep 212,0874391,041462
30 Jun 212,0746781,026434
31 Mar 211,842624905392
31 Dec 201,870606947363
30 Sep 201,818546930348
30 Jun 201,744287898337
31 Mar 201,826310945349
31 Dec 191,554231820326
30 Sep 191,540218818362
30 Jun 191,405187771342
31 Mar 191,314176729316
31 Dec 181,224167672304
30 Sep 181,186202654242
30 Jun 181,110187513326
31 Mar 181,081225528257
31 Dec 171,026258525203
30 Sep 171,016264558147
30 Jun 171,0152946680
31 Mar 179903416010
31 Dec 161,0353696190
30 Sep 169873645790
31 Dec 159153455090
31 Dec 147042713790
31 Dec 134811802610

Kaliteli Kazançlar: 300558 büyük bir tek seferlik kazanç ile CN¥159.4M, 30th September, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: 300558 'nin mevcut net kar marjları (16.7%) geçen yılın (12.6%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300558 şirketinin kazançları son 5 yılda yılda 3.4% oranında azaldı.

Büyüme Hızlandırma: 300558 'un son bir yıldaki kazanç büyümesi ( 32.3% ) 5 yıllık ortalamasını (yıllık -3.4% ) aşıyor.

Kazançlar vs. Sektör: 300558 geçen yılki kazanç büyümesi ( 32.3% ) Pharmaceuticals sektörünün -2.5% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 300558 'nin Özsermaye Getirisi ( 7.8% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin